Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryohei Kawabata
Observed name:
R. Kawabata
Institution:
Sakai City Medical Center
Observed institution:
Sakai City Medical Center
ORCID:
0000-0001-7386-1096
Observed ORCID:
0000-0001-7386-1096
OpenAlex ID:
A5121060613
Metabolic and functional pathways of gut microbiota in patients with gastric cancer
2026
·
Ryo Matoba
, Hiroshi Iijima
, et al.
·
Scientific Reports
PDF
A prospective, multicenter, observational study of trastuzumab deruxtecan in elderly patients with HER2-positive gastric cancer: EN-COURAGE
2026
·
Y. Narita
, R. Kawabata
, et al.
·
ESMO Gastrointestinal Oncology
PDF
472TiP Comprehensive biomarker study of zolbetuximab plus CapeOX or SOX to identify predictors of efficacy and resistance mechanisms in patients with HER2-negative, CLDN18.2-positive gastric or gastro-oesophageal junction cancer (JACCRO GC-12AR)
2025
·
Y. Kubota
, G. Usui
, et al.
·
Annals of Oncology
Comprehensive biomarker study of zolbetuximab plus CapeOX or SOX to identify predictors of efficacy and resistance mechanisms in patients with HER2-negative, CLDN18.2-positive gastric or gastro-oesophageal junction cancer (JACCRO GC-12AR)
·
Yohei Kubota
, Genki Usui
, et al.
·
Institutional Repositories DataBase (IRDB)
Genomic profile differences between primary and recurrent tumors in recurrent gastric cancer: the Liquid-GEAR Study
·
Shinichi Nishina
, Hiroyuki Takeda
, et al.
·
Institutional Repositories DataBase (IRDB)
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type